Loading...

Richard J Bold

TitleProf
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bateni SB, Canter RJ, Meyers FJ, Galante JM, Bold R. Palliative Care Training and Decision-Making for Patients with Advanced Cancer: A Comparison of Surgeons and Medical Physicians. Surgery. 2018 Apr 27. PMID: 29709369.
      View in: PubMed
    2. Becker J, Woloszyn J, Bold R, Campbell MJ. The Adrenal Incidentaloma: An Opportunity to Improve Patient Care. J Gen Intern Med. 2018 Mar; 33(3):256-257. PMID: 29256090.
      View in: PubMed
    3. Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold R, Monjazeb AM, Canter RJ. Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. Anticancer Res. 2018 03; 38(3):1491-1497. PMID: 29491077.
      View in: PubMed
    4. Unger J, Sun T, Chen YL, Phipps JE, Bold R, Darrow MA, Ma KL, Marcu L. Method for accurate registration of tissue autofluorescence imaging data with corresponding histology: a means for enhanced tumor margin assessment. J Biomed Opt. 2018 Jan; 23(1):1-11. PMID: 29297208.
      View in: PubMed
    5. Phipps JE, Gorpas D, Unger J, Darrow M, Bold R, Marcu L. Automated detection of breast cancer in resected specimens with fluorescence lifetime imaging. Phys Med Biol. 2017 Dec 14; 63(1):015003. PMID: 29099721.
      View in: PubMed
    6. Bateni SB, Bold R, Meyers FJ, Canter DJ, Canter RJ. Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery. J Surg Oncol. 2018 Mar; 117(3):479-487. PMID: 29044598.
      View in: PubMed
    7. Whitney RL, Bell JF, Tancredi DJ, Romano PS, Bold R, Joseph JG. Hospitalization Rates and Predictors of Rehospitalization Among Individuals With Advanced Cancer in the Year After Diagnosis. J Clin Oncol. 2017 Nov 01; 35(31):3610-3617. PMID: 28850290.
      View in: PubMed
    8. Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold R, Canter RJ. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis. Ann Surg Oncol. 2017 Oct; 24(11):3252-3263. PMID: 28741123.
      View in: PubMed
    9. Reed SC, Bell JF, Whitney R, Lash R, Kim KK, Bold R, Joseph JG. Psychosocial outcomes in active treatment through survivorship. Psychooncology. 2018 Jan; 27(1):279-285. PMID: 28429466.
      View in: PubMed
    10. Park JS, Bateni SB, Bold R, Kirane AR, Canter DJ, Canter RJ. The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections. J Surg Res. 2017 Sep; 217:191-197. PMID: 28587892.
      View in: PubMed
    11. Bell JF, Whitney RL, Reed SC, Poghosyan H, Lash RS, Kim KK, Davis A, Bold R, Joseph JG. Systematic Review of Hospital Readmissions Among Patients With Cancer in the United States. Oncol Nurs Forum. 2017 03 01; 44(2):176-191. PMID: 28222076.
      View in: PubMed
    12. Lash RS, Bell JF, Reed SC, Poghosyan H, Rodgers J, Kim KK, Bold R, Joseph JG. A Systematic Review of Emergency Department Use Among Cancer Patients. Cancer Nurs. 2017 Mar/Apr; 40(2):135-144. PMID: 26925998.
      View in: PubMed
    13. Bold R. Biology Trumps Anatomic Location in Periampullary Cancers. JAMA Surg. 2017 Jan 01; 152(1):89. PMID: 27732696.
      View in: PubMed
    14. Bateni SB, David EA, Bold R, Cooke DT, Meyers FJ, Canter RJ. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 05; 161(5):1307-1314. PMID: 28011006.
      View in: PubMed
    15. Brown EG, Anderson JE, Burgess D, Bold R, Farmer DL. Pediatric surgical readmissions: Are they truly preventable? J Pediatr Surg. 2017 Jan; 52(1):161-165. PMID: 27919406.
      View in: PubMed
    16. Bateni SB, Meyers FJ, Bold R, Canter RJ. Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One. 2016; 11(10):e0165315. PMID: 27780274.
      View in: PubMed
    17. Brown EG, Anderson JE, Burgess D, Bold R. Examining the "Halo Effect" of Surgical Care Within Health Systems. JAMA Surg. 2016 10 01; 151(10):983-984. PMID: 27367923.
      View in: PubMed
    18. Yuen NK, Li CS, Monjazeb AM, Borys D, Bold R, Canter RJ. Older Age Modifies Oncologic Outcome Following Radiotherapy in Soft-tissue Sarcoma: A Subtype-specific SEER Analysis. Anticancer Res. 2016 Apr; 36(4):1745-50. PMID: 27069154.
      View in: PubMed
    19. Kim KK, Bell JF, Bold R, Davis A, Ngo V, Reed SC, Joseph JG. A Personal Health Network for Chemotherapy Care Coordination: Evaluation of Usability Among Patients. Stud Health Technol Inform. 2016; 225:232-6. PMID: 27332197.
      View in: PubMed
    20. Dyer BA, Kahn LA, Matin M, Bold R, Tanaka MI, Monjazeb AM. Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma. Cureus. 2015 Dec 15; 7(12):e406. PMID: 26824007; PMCID: PMC4725616.
    21. Whitney RL, Bell JF, Reed SC, Lash R, Bold R, Kim KK, Davis A, Copenhaver D, Joseph JG. Predictors of financial difficulties and work modifications among cancer survivors in the United States. J Cancer Surviv. 2016 Apr; 10(2):241-50. PMID: 26188363; PMCID: PMC4854648.
    22. Yuen NK, Li CS, Monjazeb AM, Borys D, Bold R, Canter RJ. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma. J Surg Res. 2015 Dec; 199(2):494-504. PMID: 26163324; PMCID: PMC4789295 [Available on 12/01/16].
    23. Brown EG, Bold R. Hospital Readmissions: Are They Preventable? Adv Surg. 2015; 49:15-29. PMID: 26299488.
      View in: PubMed
    24. Bateni SB, Meyers FJ, Bold R, Canter RJ. Current perioperative outcomes for patients with disseminated cancer. J Surg Res. 2015 Jul; 197(1):118-25. PMID: 25911950; PMCID: PMC4457583.
    25. Kim EJ, Semrad TJ, Bold R. Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers. Expert Opin Investig Drugs. 2015 Jun; 24(6):781-94. PMID: 25809274; PMCID: PMC4684166.
    26. Daylami R, Muilenburg DJ, Virudachalam S, Bold R. Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer. J Exp Clin Cancer Res. 2014 Dec 12; 33:102. PMID: 25499121; PMCID: PMC4279680.
    27. Brown EG, Canter RJ, Bold R. Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma. J Surg Oncol. 2015 Mar; 111(3):293-8. PMID: 25330934.
      View in: PubMed
    28. Brown EG, Burgess D, Li CS, Canter RJ, Bold R. Hospital readmissions: necessary evil or preventable target for quality improvement. Ann Surg. 2014 Oct; 260(4):583-9; discussion 589-91. PMID: 25203874; PMCID: PMC4217287.
    29. Mayadev J, Einck J, Elson S, Rugo H, Hwang S, Bold R, Daroui P, McCloskey S, Yashar C, Kim D, Fowble B. Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. Clin Breast Cancer. 2015 Feb; 15(1):43-7. PMID: 25245425.
      View in: PubMed
    30. Changou CA, Chen YR, Xing L, Yen Y, Chuang FY, Cheng RH, Bold R, Ann DK, Kung HJ. Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy. Proc Natl Acad Sci U S A. 2014 Sep 30; 111(39):14147-52. PMID: 25122679; PMCID: PMC4191793.
    31. Brown EG, Yang A, Canter RJ, Bold R. Outcomes of pancreaticoduodenectomy: where should we focus our efforts on improving outcomes? JAMA Surg. 2014 Jul; 149(7):694-9. PMID: 24849180.
      View in: PubMed
    32. Shah DR, Bold R, Yang AD, Khatri VP, Martinez SR, Canter RJ. Relative value units poorly correlate with measures of surgical effort and complexity. J Surg Res. 2014 Aug; 190(2):465-70. PMID: 24953983; PMCID: PMC4152374.
    33. Whitney RL, Bell JF, Bold R, Joseph JG. Mental health needs and service use in a national sample of adult cancer survivors in the USA: has psychosocial care improved? Psychooncology. 2015 Jan; 24(1):80-8. PMID: 24818821.
      View in: PubMed
    34. Muilenburg D, Parsons C, Coates J, Virudachalam S, Bold R. Role of autophagy in apoptotic regulation by Akt in pancreatic cancer. Anticancer Res. 2014 Feb; 34(2):631-7. PMID: 24510992; PMCID: PMC4565513.
    35. Mayadev J, Daly M, Chen A, Bold R, Chew H. The potential role of radiation therapy to the primary site of disease in stage IV breast cancer presenting with synchronous metastasis. Clin Breast Cancer. 2014 Feb; 14(1):10-2. PMID: 24183416.
      View in: PubMed
    36. Shah DR, Martinez SR, Canter RJ, Yang AD, Bold R, Khatri VP. Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. J Surg Oncol. 2013 Dec; 108(7):472-6. PMID: 24108568.
      View in: PubMed
    37. Canter RJ, Smith CA, Martinez SR, Goodnight JE, Bold R, Wisner DH. Extremity soft tissue tumor surgery by surgical specialty: a comparison of case volume among oncology and non-oncology-designated surgeons. J Surg Oncol. 2013 Sep; 108(3):142-7. PMID: 23893351.
      View in: PubMed
    38. Bold R. Re: CA 19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and preoperative therapy. Ann Surg Oncol. 2013 Jul; 20(7):2108-10. PMID: 23563959.
      View in: PubMed
    39. Changou CA, Wolfson DL, Ahluwalia BS, Bold R, Kung HJ, Chuang FY. Quantitative analysis of autophagy using advanced 3D fluorescence microscopy. J Vis Exp. 2013 May 03; (75):e50047. PMID: 23665532; PMCID: PMC3670569.
    40. Shah DR, Brown E, Russo JE, Li CS, Martinez SR, Coates JM, Bold R, Canter RJ. Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg. 2013 Apr; 17(4):660-7. PMID: 23345053; PMCID: PMC4143417.
    41. Shah DR, Wang H, Bold R, Yang X, Martinez SR, Yang AD, Khatri VP, Wisner DH, Canter RJ. Nomograms to predict risk of in-hospital and post-discharge venous thromboembolism after abdominal and thoracic surgery: an American College of Surgeons National Surgical Quality Improvement Program analysis. J Surg Res. 2013 Jul; 183(1):462-71. PMID: 23298949.
      View in: PubMed
    42. Shah DR, Canter RJ, Khatri VP, Bold R, Yang AD, Martinez SR. Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol. 2013 Jan; 20(1):24-30. PMID: 23054103; PMCID: PMC4601634.
    43. Bold R. Is palpation in the operating room the best method for surgical planning? Arch Surg. 2012 Sep; 147(9):875. PMID: 22987186.
      View in: PubMed
    44. Shah D, Borys D, Martinez SR, Li CS, Tamurian RM, Bold R, Monjazeb A, Canter RJ. Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res. 2012 Sep; 32(9):3911-5. PMID: 22993336; PMCID: PMC4153787.
    45. Shah DR, Galante JM, Bold R, Canter RJ, Martinez SR. Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient care. J Surg Educ. 2013 Nov-Dec; 70(6):826-34. PMID: 24209663; PMCID: PMC3824151.
    46. Martinez SR, Shah DR, Tseng WH, Canter RJ, Bold R. Rural-urban disparities in use of post-lumpectomy radiation. Med Oncol. 2012 Dec; 29(5):3250-7. PMID: 22684693.
      View in: PubMed
    47. Shah DR, Canter RJ, Khatri VP, Bold R, Martinez SR. Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res. 2012 Sep; 177(1):e21-6. PMID: 22482771; PMCID: PMC3405185.
    48. Martinez SR, Tseng WH, Shah DR, Canter RJ, Bold R. Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol. 2012 Sep; 29(3):1523-8. PMID: 21983860.
      View in: PubMed
    49. Tseng WH, Canter RJ, Bold R. Perioperative outcomes for open distal pancreatectomy: current benchmarks for comparison. J Gastrointest Surg. 2011 Nov; 15(11):2053-8. PMID: 21938560.
      View in: PubMed
    50. Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold R. Medullary carcinoma of the breast: a population-based perspective. Med Oncol. 2011 Sep; 28(3):738-44. PMID: 20390465; PMCID: PMC4596814.
    51. Smith CA, Martinez SR, Tseng WH, Tamurian RM, Bold R, Borys D, Canter RJ. Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res. 2012 Jun 01; 175(1):12-7. PMID: 21920555.
      View in: PubMed
    52. Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold R, Canter RJ. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug; 254(2):333-8. PMID: 21677562.
      View in: PubMed
    53. Martinez SR, Tseng WH, Canter RJ, Chen AM, Chen SL, Bold R. Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer. 2012 Jan 01; 118(1):196-204. PMID: 21692066.
      View in: PubMed
    54. Tseng WH, Jin L, Canter RJ, Martinez SR, Khatri VP, Gauvin J, Bold R, Wisner D, Taylor S, Chen SL. Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg. 2011 Jul; 213(1):19-26; discussion 26-8. PMID: 21493108.
      View in: PubMed
    55. Vanderveen KA, Canter RJ, Yin D, Cress RD, Bold R. Factors affecting treatment delivery and outcomes of patients with early-stage pancreatic adenocarcinoma. Pancreas. 2011 Apr; 40(3):480-2. PMID: 21412120.
      View in: PubMed
    56. Tseng WH, Martinez SR, Tamurian RM, Chen SL, Bold R, Canter RJ. Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol. 2011 Apr; 103(5):390-4. PMID: 21400521.
      View in: PubMed
    57. Tseng WH, Stevenson TR, Canter RJ, Chen SL, Khatri VP, Bold R, Martinez SR. Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg. 2010 Dec; 126(6):1815-24. PMID: 21124121; PMCID: PMC3058849.
    58. Coates JM, Martinez SR, Bold R, Chen SL. Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol. 2010 Sep 15; 102(4):342-7. PMID: 20589709.
      View in: PubMed
    59. Parsons CM, Muilenburg D, Bowles TL, Virudachalam S, Bold R. The role of Akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Res. 2010 Sep; 30(9):3279-89. PMID: 20944098; PMCID: PMC4557882.
    60. Martinez SR, Beal SH, Chen SL, Canter RJ, Khatri VP, Chen A, Bold R. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):787-92. PMID: 20619550; PMCID: PMC2946458.
    61. Bold R. Finding the problems before fixing them: the culture of perioperative safety. Arch Surg. 2010 Jun; 145(6):589. PMID: 20575191.
      View in: PubMed
    62. Muilenburg DJ, Coates JM, Virudachalam S, Bold R. Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancer. J Surg Res. 2010 Oct; 163(2):276-81. PMID: 20452611; PMCID: PMC2929291.
    63. Beal SH, Martinez SR, Canter RJ, Chen SL, Khatri VP, Bold R. Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol. 2010 Dec; 27(4):1420-4. PMID: 20049562; PMCID: PMC2930938.
    64. Canter RJ, Beal S, Borys D, Martinez SR, Bold R, Robbins AS. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg. 2010 Feb; 210(2):191-198.e2. PMID: 20113939.
      View in: PubMed
    65. Harms NJ, Naderi S, Borys D, Bold R, Canter RJ. Complex diaphragm reconstruction using dermal collagen matrix after multivisceral resection of retroperitoneal sarcoma. J Thorac Cardiovasc Surg. 2010 Apr; 139(4):1081-3. PMID: 19853863.
      View in: PubMed
    66. Coates JM, Beal SH, Russo JE, Vanderveen KA, Chen SL, Bold R, Canter RJ. Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Arch Surg. 2009 Sep; 144(9):841-7. PMID: 19797109.
      View in: PubMed
    67. Coates JM, Galante JM, Bold R. Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res. 2010 Dec; 164(2):301-8. PMID: 20031162.
      View in: PubMed
    68. Hausner SH, Abbey CK, Bold R, Gagnon MK, Marik J, Marshall JF, Stanecki CE, Sutcliffe JL. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009 Jul 15; 69(14):5843-50. PMID: 19549907; PMCID: PMC2711989.
    69. Vanderveen KA, Chen SL, Yin D, Cress RD, Bold R. Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis. Cancer. 2009 Jun 01; 115(11):2420-9. PMID: 19301434; PMCID: PMC2748401.
    70. Kim RH, Bold R, Kung HJ. ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer. Autophagy. 2009 May; 5(4):567-8. PMID: 19276647; PMCID: PMC4294541.
    71. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold R, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009 Jan 15; 69(2):700-8. PMID: 19147587; PMCID: PMC2629384.
    72. Bowles TL, Kim R, Galante J, Parsons CM, Virudachalam S, Kung HJ, Bold R. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer. 2008 Oct 15; 123(8):1950-5. PMID: 18661517; PMCID: PMC4294549.
    73. Parsons CM, Sutcliffe JL, Bold R. Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008; 15(4):429-35. PMID: 18670846.
      View in: PubMed
    74. Galante JM, Mortenson MM, Bowles TL, Virudachalam S, Bold R. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J Surg Res. 2009 Mar; 152(1):18-25. PMID: 19062038.
      View in: PubMed
    75. Vanderveen KA, Ramsamooj R, Bold R. A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol. 2008 Jul; 15(7):2006-11. PMID: 18481152.
      View in: PubMed
    76. Vanderveen K, Bold R. Effect of generational composition on the surgical workforce. Arch Surg. 2008 Mar; 143(3):224-6. PMID: 18347267.
      View in: PubMed
    77. Martinez SR, Robbins AS, Meyers FJ, Bold R, Khatri VP, Goodnight JE. Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer. 2008 Mar 01; 112(5):1162-8. PMID: 18213619.
      View in: PubMed
    78. Davies AM, Ruel C, Lara PN, Lau DH, Gumerlock PH, Bold R, Shibata S, Lenz HJ, Schenkein DP, Gandara DR. The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study. J Thorac Oncol. 2008 Jan; 3(1):68-74. PMID: 18166843.
      View in: PubMed
    79. Mortenson MM, Galante JG, Gilad O, Schlieman MG, Virudachalam S, Kung HJ, Bold R. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem. 2007 Dec 01; 102(5):1171-9. PMID: 17960583.
      View in: PubMed
    80. Redwine J, Bold R. Perioperative care of the patient with hemophilia undergoing urgent appendectomy. Arch Surg. 2007 Sep; 142(9):894-7. PMID: 17875845.
      View in: PubMed
    81. Vanderveen KA, Paterniti DA, Kravitz RL, Bold R. Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol. 2007 May; 14(5):1662-9. PMID: 17285395.
      View in: PubMed
    82. Wang H, Ryu J, Gandara D, Bold R, Urayama S, Tanaka M, Goldberg Z, Follette D, Narayan S, Lau D. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol. 2007 Feb; 2(2):153-7. PMID: 17410032.
      View in: PubMed
    83. Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold R. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol. 2006 Nov; 13(11):1450-6. PMID: 17009150.
      View in: PubMed
    84. Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. 2006 May; 17(4):403-9. PMID: 16596292.
      View in: PubMed
    85. Bold R. Re: Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors, by Bufalari A, Giustozzi G, Burattini MF, et al. J Surg Oncol. 2006 Mar 01; 93(3):167-8. PMID: 16482591.
      View in: PubMed
    86. Davies AM, Lara PN, Mack PC, Gumerlock PH, Bold R, Gandara DR. Bortezomib-based combinations in the treatment of non-small-cell lung cancer. Clin Lung Cancer. 2005 Oct; 7 Suppl 2:S59-63. PMID: 16250929.
      View in: PubMed
    87. Lara PN, Bold R, Mack PC, Davies AM, Gumerlock PH, Gandara DR. Proteasome inhibition in small-cell lung cancer: preclinical rationale and clinical applications. Clin Lung Cancer. 2005 Oct; 7 Suppl 2:S67-71. PMID: 16250931.
      View in: PubMed
    88. Mortenson MM, Ho HS, Bold R. An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer. Am J Surg. 2005 Sep; 190(3):406-11. PMID: 16105527.
      View in: PubMed
    89. Galante JM, Bowles TL, Khatri VP, Schneider PD, Goodnight JE, Bold R. Experience and attitudes of surgeons toward palliation in cancer. Arch Surg. 2005 Sep; 140(9):873-8; discussion 878-80. PMID: 16172296.
      View in: PubMed
    90. Mortenson MM, Schlieman MG, Virudachalam S, Lara PN, Gandara DG, Davies AM, Bold R. Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer. Lung Cancer. 2005 Aug; 49(2):163-70. PMID: 16022909.
      View in: PubMed
    91. Fahy BN, Schlieman MG, Mortenson MM, Virudachalam S, Bold R. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol. 2005 Jul; 56(1):46-54. PMID: 15791457.
      View in: PubMed
    92. Bold R. A young surgeon's perspective. Arch Surg. 2005 Mar; 140(3):254-7. PMID: 15781788.
      View in: PubMed
    93. Bold R. Standardization of sentinel lymph node biopsy in breast carcinoma. Cancer. 2005 Feb 01; 103(3):444-6. PMID: 15612082.
      View in: PubMed
    94. Mortenson MM, Schneider PD, Khatri VP, Stevenson TR, Whetzel TP, Sommerhaug EJ, Goodnight JE, Bold R. Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg. 2004 Sep; 139(9):988-91. PMID: 15381618.
      View in: PubMed
    95. Mortenson MM, Schlieman MG, Virudachalam S, Bold R. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol. 2004 Oct; 54(4):343-53. PMID: 15197486.
      View in: PubMed
    96. Fahy BN, Schlieman MG, Virudachalam S, Bold R. Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg. 2004 Apr; 198(4):591-9. PMID: 15051014.
      View in: PubMed
    97. Bold R, Goodnight JE. Hilar cholangiocarcinoma: surgical and endoscopic approaches. Surg Clin North Am. 2004 Apr; 84(2):525-42. PMID: 15062660.
      View in: PubMed
    98. Lara PN, Davies AM, Mack PC, Mortenson MM, Bold R, Gumerlock PH, Gandara DR. Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy. Semin Oncol. 2004 Feb; 31(1 Suppl 1):40-6. PMID: 14981579.
      View in: PubMed
    99. Bold R. "Development of the proteasome inhibitor Velcade (Bortezomib)" by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D. Cancer Invest. 2004; 22(2):328-9. PMID: 15199617.
      View in: PubMed
    100. Khatri VP, Galante JM, Bold R, Schneider PD, Ramsamooj R, Goodnight JE. Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol. 2003 Nov; 10(9):1118-22. PMID: 14597453.
      View in: PubMed
    101. Monson K, Litvak DA, Bold R. Surgery in the aged population: surgical oncology. Arch Surg. 2003 Oct; 138(10):1061-7. PMID: 14557121.
      View in: PubMed
    102. Schlieman MG, Ho HS, Bold R. Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg. 2003 Sep; 138(9):951-5; discussion 955-6. PMID: 12963650.
      View in: PubMed
    103. Fahy BN, Schlieman MG, Virudachalam S, Bold R. Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer. J Surg Res. 2003 Jul; 113(1):88-95. PMID: 12943815.
      View in: PubMed
    104. Nawrocki ST, Bruns CJ, Harbison MT, Bold R, Gotsch BS, Abbruzzese JL, Elliott P, Adams J, McConkey DJ. Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther. 2002 Dec; 1(14):1243-53. PMID: 12516957.
      View in: PubMed
    105. Althausen PL, Schneider PD, Bold R, Gupta MC, Goodnight JE, Khatri VP. Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine (Phila Pa 1976). 2002 Aug 01; 27(15):E361-5. PMID: 12163737.
      View in: PubMed
    106. Stein M, Schneider PD, Ho HS, Eckert R, Urayama S, Bold R. Percutaneous transhepatic portography with intravascular ultrasonography for evaluation of venous involvement of hepatobiliary and pancreatic tumors. J Vasc Interv Radiol. 2002 Aug; 13(8):805-14. PMID: 12171984.
      View in: PubMed
    107. Fahy BN, Bold R, Beckett L, Schneider PD. Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg. 2002 Aug; 137(8):917-22; discussion 922-3. PMID: 12146990.
      View in: PubMed
    108. Bold R. Re: Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg. 2002 May; 68(5):500; author reply 500. PMID: 12013299.
      View in: PubMed
    109. Fahy BN, Frey CF, Ho HS, Beckett L, Bold R. Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg. 2002 Mar; 183(3):237-41. PMID: 11943118.
      View in: PubMed
    110. Bold R. Surgical management of breast cancer: today and tomorrow. Cancer Biother Radiopharm. 2002 Feb; 17(1):1-9. PMID: 11915165.
      View in: PubMed
    111. Schlieman M, Stein M, McVicar J, Bold R. Hepatic artery aneurysm within focal nodular hyperplasia. J Hepatol. 2002 Feb; 36(2):302. PMID: 11830345.
      View in: PubMed
    112. Braley SC, Schneider PD, Bold R, Goodnight JE, Khatri VP. Controlled tamponade of severe presacral venous hemorrhage: use of a breast implant sizer. Dis Colon Rectum. 2002 Jan; 45(1):140-2. PMID: 11786781.
      View in: PubMed
    113. Mortenson M, Bold R. Symptomatic pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma). Int J Gastrointest Cancer. 2002; 32(2-3):153-6. PMID: 12794252.
      View in: PubMed
    114. Bold R, Ota DM, Ajani JA, Mansfield PF. Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer. Gastric Cancer. 1999 May; 2(1):1-7. PMID: 11957063.
      View in: PubMed